カテゴリー： IMARC, 世界, 医療/バイオ

静脈内溶液の世界市場2023～2028：産業動向、シェア、規模、成長、機会・予測

◆英語タイトル：Intravenous Solutions Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028

IMARCが発行した調査報告書（IMARC23JLY127）◆商品コード：IMARC23JLY127
◆発行会社（リサーチ会社）：IMARC
◆発行日：2023年7月
◆ページ数：149
◆レポート形式：英語 / PDF
◆納品方法：Eメール
◆調査対象地域：グローバル
◆産業分野：医療
◆販売価格オプション（消費税別）
Single UserUSD2,999 ⇒換算￥455,848見積依頼/購入/質問フォーム
Five UserUSD3,999 ⇒換算￥607,848見積依頼/購入/質問フォーム
EnterprisewideUSD4,999 ⇒換算￥759,848見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

アイマーク社の本市場調査資料によると、2022年に140億ドルであった世界の静脈内溶液市場規模が、2028年までに196億ドルに達し、予測期間中（2023-2028）にCAGR 5.8%成長すると予想しています。本資料では、静脈内溶液の世界市場について調査・分析し、序論、市場範囲・定義、エグゼクティブサマリー、イントロダクション、市場概況、種類別（部分静脈栄養、完全静脈栄養）分析、栄養素別（炭水化物、塩分・電解質、ミネラル、ビタミン、その他）分析、地域別（北米、ヨーロッパ、アジア太平洋、中東・アフリカ、中南米）分析、製造プロセス、競争状況などの内容をまとめています。なお、本資料には、Ajinomoto Co., Inc.、B. Braun Melsungen AG、Baxter International, Inc.、Grifols S.A.、Otsuka Pharmaceuticalなどの企業情報が含まれています。
・序論
・市場範囲・定義
・エグゼクティブサマリー
・イントロダクション
・市場概況
・世界の静脈内溶液市場規模：種類別
- 部分静脈栄養の市場規模
- 完全静脈栄養の市場規模
・世界の静脈内溶液市場規模：栄養素別
- 炭水化物の市場規模
- 塩分・電解質の市場規模
- ミネラルの市場規模
- ビタミンの市場規模
- その他栄養素の市場規模
・世界の静脈内溶液市場規模：地域別
- 北米の静脈内溶液市場規模
- ヨーロッパの静脈内溶液市場規模
- アジア太平洋の静脈内溶液市場規模
- 中東・アフリカの静脈内溶液市場規模
- 中南米の静脈内溶液市場規模
・製造プロセス
・競争状況

Market Overview:

The global intravenous solutions market size reached US$ 14.0 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 19.6 Billion by 2028, exhibiting a growth rate (CAGR) of 5.8% during 2023-2028.

Intravenous (IV) solutions are supplemental fluids comprising water, electrolytes, sugar, and medications. They are given to patients according to their requirements, medical condition, age, and body size to restore fluid volume and treat electrolyte balance. At present, they are widely used in IV therapy to replace electrolyte losses, administer drugs and blood products, and supply essential nutrients to the intravascular fluid compartment.

Intravenous Solutions Market Trends:
Due to the sudden outbreak of coronavirus disease (COVID-19), there is a rise in the demand for IV solutions worldwide to provide essential nutrients to patients in the intensive care unit (ICU). Apart from this, the increasing number of people who have diabetes, cancer, gastrointestinal disorder, and neurological diseases represents another major growth-inducing factor. Moreover, the faster response time and higher efficacy associated with IV solution therapy is contributing to market growth. It is used to overcome chronic dehydration that can cause fatigue, memory problems, irritability, and other medical conditions. This, along with the increasing participation of individuals in physical activities, is influencing the adoption of IV solutions for a fast recovery. IV solutions are also utilized to improve skin conditions and treat migraines and hangovers. Besides this, leading manufacturers are introducing easy-to-use, portable product variants that can be used as drips at home. Additionally, due to rising environmental concerns, they are developing premixed solutions that reduce the amount of packaging waste. Furthermore, rising investments by health agencies of numerous countries in the healthcare sector are anticipated to create a favorable market outlook.

Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global intravenous solutions market report, along with forecasts at the global and regional level from 2023-2028. Our report has categorized the market based on type and nutrients.

Breakup by Type:
Partial Parenteral Nutrition
Total Parenteral Nutrition

Total parenteral nutrition is currently the most preferred type of IV solution as it helps prevent malnutrition and maintain energy.

Breakup by Nutrients:
Carbohydrates
Salts and Electrolytes
Minerals
Vitamins
Amino Acids

Breakup by Region:
North America
Europe
Asia Pacific
Middle East and Africa
Latin America

Presently, North America enjoys the leading position in the market due to the increasing prevalence of chronic diseases in the region.

Competitive Landscape:
The competitive landscape of the market has been analyzed in the report, along with the detailed profiles of the major players operating in the industry. Some of these players are Ajinomoto Co., Inc., B. Braun Melsungen AG, Baxter International, Inc., Grifols S.A., and Otsuka Pharmaceutical.

Key Questions Answered in This Report
1. What is the expected growth rate of the global intravenous solutions market during 2023-2028?
2. What are the key factors driving the global intravenous solutions market?
3. What has been the impact of COVID-19 on the global intravenous solutions market?
4. What is the breakup of the global intravenous solutions market based on the type?
5. What is the breakup of the global intravenous solutions market based on the nutrients?
6. What are the key regions in the global intravenous solutions market?
7. Who are the key players/companies in the global intravenous solutions market?

❖ レポートの目次 ❖

1 Preface
2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
4.1 Overview
4.2 Key Industry Trends
5 Global Intravenous Solutions Market
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Breakup by Type
5.5 Market Breakup by Nutrients
5.6 Market Breakup by Region
5.7 Market Forecast
5.8 SWOT Analysis
5.8.1 Overview
5.8.2 Strengths
5.8.3 Weaknesses
5.8.4 Opportunities
5.8.5 Threats
5.9 Value Chain Analysis
5.9.1 Overview
5.9.2 Research and Development
5.9.3 Raw Material Procurement
5.9.4 Manufacturing
5.9.5 Marketing
5.9.6 Distribution
5.9.7 End-Use
5.10 Porters Five Forces Analysis
5.10.1 Overview
5.10.2 Bargaining Power of Buyers
5.10.3 Bargaining Power of Suppliers
5.10.4 Degree of Competition
5.10.5 Threat of New Entrants
5.10.6 Threat of Substitutes
6 Market Breakup by Type
6.1 Partial Parenteral Nutrition
6.1.1 Market Trends
6.1.2 Market Forecast
6.2 Total Parenteral Nutrition
6.2.1 Market Trends
6.2.2 Market Forecast
7 Market Breakup by Nutrients
7.1 Carbohydrates
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Salts and Electrolytes
7.2.1 Market Trends
7.2.2 Market Forecast
7.3 Minerals
7.3.1 Market Trends
7.3.2 Market Forecast
7.4 Vitamins
7.4.1 Market Trends
7.4.2 Market Forecast
7.5 Amino Acids
7.5.1 Market Trends
7.5.2 Market Forecast
8 Market Breakup by Region
8.1 North America
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Europe
8.2.1 Market Trends
8.2.2 Market Forecast
8.3 Asia Pacific
8.3.1 Market Trends
8.3.2 Market Forecast
8.4 Middle East and Africa
8.4.1 Market Trends
8.4.2 Market Forecast
8.5 Latin America
8.5.1 Market Trends
8.5.2 Market Forecast
9 Intravenous Solutions Manufacturing Process
9.1 Product Overview
9.2 Raw Material Requirements
9.3 Manufacturing Process
9.4 Key Success and Risk Factors
10 Competitive Landscape
10.1 Market Structure
10.2 Key Players
10.3 Profiles of Key Players
10.3.1 Ajinomoto
10.3.1.1 Company Overview
10.3.1.2 Description
10.3.1.3 Product Portfolio
10.3.1.4 Financials
10.3.1.5 SWOT Analysis
10.3.2 B. Braun Melsungen
10.3.2.1 Company Overview
10.3.2.2 Description
10.3.2.3 Product Portfolio
10.3.2.4 Financials
10.3.2.5 SWOT Analysis
10.3.3 Baxter International Inc.
10.3.3.1 Company Overview
10.3.3.2 Description
10.3.3.3 Product Portfolio
10.3.3.4 Financials
10.3.3.5 SWOT Analysis
10.3.4 Grifols
10.3.4.1 Company Overview
10.3.4.2 Description
10.3.4.3 Product Portfolio
10.3.4.4 Financials
10.3.4.5 SWOT Analysis
10.3.5 Otsuka Pharmaceutical
10.3.5.1 Company Overview
10.3.5.2 Description
10.3.5.3 Product Portfolio

Figure 1: Global: Intravenous Solutions Market: Major Drivers and Challenges
Figure 2: Global: Intravenous Solutions Market: Sales Value (in Billion US$), 2017-2022
Figure 3: Global: Intravenous Solutions Market: Breakup by Type (in %), 2022
Figure 4: Global: Intravenous Solutions Market: Breakup by Nutrients (in %), 2022
Figure 5: Global: Intravenous Solutions Market: Breakup by Region (in %), 2022
Figure 6: Global: Intravenous Solutions Market Forecast: Sales Value (in Billion US$), 2023-2028
Figure 7: Global: Intravenous Solutions Industry: SWOT Analysis
Figure 8: Global: Intravenous Solutions Industry: Value Chain Analysis
Figure 9: Global: Intravenous Solutions Industry: Porter’s Five Forces Analysis
Figure 10: Global: Intravenous Solutions (Partial Parenteral Nutrition) Market: Sales Value (in Million US$), 2017 & 2022
Figure 11: Global: Intravenous Solutions (Partial Parenteral Nutrition) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 12: Global: Intravenous Solutions (Total Parenteral Nutrition) Market: Sales Value (in Million US$), 2017 & 2022
Figure 13: Global: Intravenous Solutions (Total Parenteral Nutrition) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 14: Global: Intravenous Solutions (Carbohydrates) Market: Sales Value (in Million US$), 2017 & 2022
Figure 15: Global: Intravenous Solutions (Carbohydrates) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 16: Global: Intravenous Solutions (Salts and Electrolytes) Market: Sales Value (in Million US$), 2017 & 2022
Figure 17: Global: Intravenous Solutions (Salts and Electrolytes) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 18: Global: Intravenous Solutions (Minerals) Market: Sales Value (in Million US$), 2017 & 2022
Figure 19: Global: Intravenous Solutions (Minerals) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 20: Global: Intravenous Solutions (Vitamins) Market: Sales Value (in Million US$), 2017 & 2022
Figure 21: Global: Intravenous Solutions (Vitamins) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 22: Global: Intravenous Solutions (Amino Acids) Market: Sales Value (in Million US$), 2017 & 2022
Figure 23: Global: Intravenous Solutions (Amino Acids) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 24: North America: Intravenous Solutions Market: Sales Value (in Million US$), 2017 & 2022
Figure 25: North America: Intravenous Solutions Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 26: Europe: Intravenous Solutions Market: Sales Value (in Million US$), 2017 & 2022
Figure 27: Europe: Intravenous Solutions Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 28: Asia Pacific: Intravenous Solutions Market: Sales Value (in Million US$), 2017 & 2022
Figure 29: Asia Pacific: Intravenous Solutions Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 30: Middle East and Africa: Intravenous Solutions Market: Sales Value (in Million US$), 2017 & 2022
Figure 31: Middle East and Africa: Intravenous Solutions Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 32: Latin America: Intravenous Solutions Market: Sales Value (in Million US$), 2017 & 2022
Figure 33: Latin America: Intravenous Solutions Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 34: Intravenous Solutions Manufacturing: Detailed Process Flow

❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer
★リサーチレポート[ 静脈内溶液の世界市場2023～2028：産業動向、シェア、規模、成長、機会・予測(Intravenous Solutions Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028)]についてメールでお問い合わせはこちらでお願いします。
◆関連リサーチレポート◆
  • ナフサの世界市場2023～2028：産業動向、シェア、規模、成長、機会・予測
  • 人工臓器の世界市場2023-2028：産業動向、シェア、規模、成長、機会・予測
  • ビジョンケアの世界市場2022-2028：産業動向、シェア、規模、成長、機会・予測
  • 消化管治療薬の世界市場2023～2028：産業動向、シェア、規模、成長、機会・予測
  • カテーテルの世界市場2023～2028：産業動向、シェア、規模、成長、機会・予測

    • ◆H&Iグローバルリサーチのお客様（例）◆